secwatch.observer — SEC 8-K summary
======================================

Issuer:     Esperion Therapeutics, Inc. (ESPR)
CIK:        0001434868
Form:       8-K
Filed at:   2023-03-22T23:59:59+00:00
Accession:  0001104659-23-035634
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Esperion raises ~$56.7M in registered direct offering; amends warrants to lower exercise price
--------------------------------------------------------------------------------

- Gross proceeds of ~$56.7M from sale of 33,170,747 shares (or equivalents) and warrants at $1.675 combined.
- Net proceeds expected ~$51.3M after placement agent fees and expenses.
- Short-term warrants exercisable at $1.55/share for 3.5 years; pre-funded warrants also offered.
- Amended 9,024,212 existing warrants from $9.00 to $1.55 exercise price for $0.125 per amended warrant.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1434868/000110465923035634/0001104659-23-035634-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1434868/000110465923035634/tm2310183d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-035634

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer